Detalles de la búsqueda
1.
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Cancer
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38752572
2.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Oncologist
; 29(5): e622-e634, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175669
3.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1709-1723, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625938
4.
Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
Ann Surg Oncol
; 30(8): 4657-4668, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809608
5.
Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment.
Curr Opin Oncol
; 34(6): 635-642, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36000362
6.
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests.
Int J Mol Sci
; 23(21)2022 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362392
7.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875670
8.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152285
9.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast Cancer Res
; 22(1): 45, 2020 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404150
10.
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Breast Cancer Res Treat
; 182(2): 401-409, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32500397
11.
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.
Breast Cancer Res Treat
; 184(2): 421-431, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770287
12.
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients.
Future Oncol
; 16(22): 1629-1637, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32501121
13.
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Lancet Oncol
; 20(10): 1360-1369, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31494037
14.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1725-1726, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809405
15.
ASO Author Reflections: A Perspective on Nonsentinel Axillary Lymph Node Status in Sentinel Lymph Node-Positive Early Breast Cancer After Primary Systemic Therapy and ALND-Predict.
Ann Surg Oncol
; 30(9): 5705-5706, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36820935
16.
ASO Visual Abstract: Nonsentinel Axillary Lymph-Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph-Node-A Predictive Model Proposal.
Ann Surg Oncol
; 30(9): 5707-5708, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37405668
17.
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
Breast J
; 25(6): 1310-1311, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338934
18.
Therapeutic resistance and optimal drug sequencing in HER2-positive metastatic breast cancer: unmet needs and future perspectives.
Heliyon
; 10(1): e23367, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38163142
19.
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study.
Cells
; 13(7)2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38607036
20.
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
EBioMedicine
; 102: 105043, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447275